| Plenary and Parallel Sessions |
| Sunday |
|
| 8:00-8:30am |
Transplant Plenary I |
| 10:30am-Noon |
Transplant Plenary II |
| 3:00-4:30pm |
Parallel 01: Bile Acid Transport and Liquid Metabolism |
| |
Parallel 02: Complications of Cirrhosis: Translational |
| |
Parallel 03: HCV: Molecular Biology and Virology |
| |
Parallel 04: HCV Treatment: Optimizing Response |
| |
Parallel 05: Liver Transplantation: Outcomes and Complications |
| |
Parallel 06: Stem Cell Biology |
| 4:45-6:15pm |
Parallel 07: Alcohol-Related Liver Disease |
| |
Parallel 08: Cholangiocyte Biology and Experimental Cholestasis |
| |
Parallel 09: Clinical Trials in HCV |
| |
Parallel 10: Complications of Cirrhosis: Experimental |
| |
Parallel 11: Donor Allocation Issues in Liver Transplantation |
| |
Parallel 12: Epidemiology of HBV and HCV |
| |
Parallel 13: Inflammation and Immunobiology |
| Monday |
|
| 8:00-9:30am |
Presidential Plenary I |
| 11:00-12:30am |
Presidential Plenary II |
| 3:00-4:30pm |
Parallel 14: Basic Cell Biology |
|
Parallel 15: HBV: Virology and Pathogenesis |
|
Parallel 16: HCV: Clinical Benefits of Treatment Response |
|
Parallel 17: HCV Therapy: Mechanisms |
|
Parallel 18: Hepatic Stellate Cell Biology |
|
Parallel 19: Hepatocellular Carcinoma: Clinical and Experimental |
|
Parallel 20: Pediatric Liver Disease: Experimental Models, Pre-clinical |
|
Parallel 21: Steatohepatitis: Experimental |
| 4:45-6:15pm |
Parallel 22: Autoimmune Liver Disease and Cholestasis |
|
Parallel 23: Cell Structure and Function |
|
Parallel 24: Clinical and Experimental Hepatotoxicity |
|
Parallel 25: Experimental Fibrosis |
|
Parallel 26: HCV: Immunology and Pathogenesis |
|
Parallel 27: Steatohepatitis: Clinical |
|
Parallel 28: The Challenge of Post-Transplant Viral Hepatitis |
| Tuesday |
|
| 8:00-9:30am |
Presidential Plenary III |
| 11:30am-1:00pm |
Parallel 29: Acute Liver Failure: Clinical and Experimental |
|
Parallel 30: Complications of Cirrhosis: Clinical |
|
Parallel 31: Diagnosis and Treatment of Hepatic Fibrosis |
|
Parallel 32: HCV: Treatment Issues and Clinical Trials |
|
Parallel 33: HCV Therapy: Pre-Clinical and Early Clinical Development |
|
Parallel 34: Molecular Pathogenesis of Metabolic Liver Disease |
|
Parallel 35: Pediatric Liver Disease: Clinical and Translational |
|
|
| Poster Sessions |
| Saturday |
|
| Session I: 2:00-8:00pm |
Acute Liver Failure |
|
Complications of Cirrhosis: Ascites and Encephalopathy |
|
Complications of Cirrhosis: Experimental |
|
Complications of Cirrhosis: Clinical Partial Hypertensive and Varices |
|
Hepatitis B: Clinical Trials and Treatment |
|
Liver Transplantation |
| Sunday |
|
| Session II: 8:00 am-5:30pm |
Effectiveness of Clinical Practice and Healthcare Delivery |
|
Experimental Cholestasis |
|
Alcohol-Related Liver Disease |
|
Basic Cell Biology |
|
Biliary Atresia, Viral and Autoimmune Hepatitis |
|
Cellular Immunobiology, Preservation and Cell Transplantation |
|
HCV: Epidemiology |
|
HCV: Treatment |
|
Hepatitis D and E |
|
Hepatobiliary Imaging |
|
Metabolic Liver Disease |
|
Pediatric Liver Disease and Transplantation |
|
Steatohepatitis: Clinical |
| Monday |
|
| Session III: 8:00am-5:30pm |
Cholangiocyte Biology |
|
Hepatobiliary Cancer: Experimental 1 |
|
Inflammation and Immunobiology |
|
Stem Cells and Gene Expression |
|
Viral Hepatitis: Co-morbidities |
|
Viral Hepatitis: Virology and Pathogenesis |
|
Fibrosis |
|
Organic Anion Transport, Bilirubin and Bile Acid Metabolism |
|
Late-Breaking Abstracts |
| Tuesday |
|
| Session IV: 8:00am-12:30pm |
Autoimmune Liver Disease and Cholestasis |
|
HCV Therapy: Pre-Clinical and Clinical Development |
|
HCV Diagnosis and Natural History |
|
Hepatobiliary Cancer: Experimental 2 |
|
Hepatobiliary Cancer: Clinical |
|
Hepatotoxicity and Drug Metabolism |
|
Steatohepatitis: Experimental and Translational |